|
OVERVIEW
Management of patients with dystonia and spasticity aims to improve activities of daily living by
improving mobility, reducing muscle tone, providing pain relief, and prevention of contractures. The
emphasis on dystonia and spasticity in training curricula for neurology as well as physical medicine
and rehabilitation residents and fellows is variable, with important aspects often lacking. For example,
very few residents and fellows receive any structured training in the appropriate use and administration
of chemodenervation agents.
A critical review of the literature, clinical trial data, and understanding of distinctions between botulinum
neurotoxin products and between different varieties of increased muscle tone are essential to
appropriately treat and manage patients with dystonia and spasticity, as is hands-on injection training.
Popular in previous years, this complementary workshop is offered again in 2011 to provide residents
and fellows, with particular interest in neurotoxins, a unique opportunity to improve their
knowledge and competence in treating patients with dystonia and spasticity. The workshop curriculum
includes interactive, evidence-based presentations and dynamic hands-on injection training, as
demonstrated by expert faculty on actual dystonia and spasticity patients.
Return to Top
GOAL
The purpose of the Fifth Annual Johns Hopkins Dystonia and Spasticity Practicum will be to
educate residents and fellows in neurology and physical medicine and rehabilitation, community
neurologists, physiatrists, and physical and occupational therapists on the science and clinical issues
related to the management of patients with dystonia and spasticity. This educational activity seeks to
also provide attendees with in-depth, evidence-based education including hands-on experience in
treating patients with dystonia and spasticity.
Return to Top
INTENDED AUDIENCE
This activity is designed for residents and fellows in neurology and physical
medicine and rehabilitation, community neurologists, physiatrists, and physical and occupational
therapists. No prerequisites required.
Return to Top
AGENDA
8:30 – 9:00 AM |
Registration and Breakfast |
9:00 – 9:25 AM |
Conference Goals and Pre-Assessment |
9:25 – 10:20 AM |
Dystonia: Introduction and Overview |
10:20 – 11:15 AM |
Spasticity: Introduction and Overview |
11:15 – 11:30 AM |
Break
|
11:30 – 12:25 PM |
Chemodenervation: Basics and Practical Considerations
|
12:25 – 1:00 PM |
Lunch: Reflection/Discussion with Faculty
|
1:00 – 3:00 PM |
Breakout Sessions: Injection Training Workshops
|
| - Models (ELVIS/ELVIRA)
- Patients with Dystonia
- Patients with Spasticity
|
3:00 – 3:45 PM |
Practical Application Workshop with Case
Selection Tool*
|
3:45 – 4:00 PM |
Educational Outcomes Activity
|
4:00 – 4:15 PM |
Question & Answer/Discussion and Concluding Remarks
|
*Please select the cases that are the most interesting to you. The 2 most popular case studies will be presented.
Return to Top
FACULTY
Zoltan Mari, MD (Chairperson)
Director, National Parkinson Foundation
Center of Excellence
Assistant Professor of Neurology
Johns Hopkins University School of Medicine
Cynthia L. Comella, MD, FAAN
Professor
Rush University Medical Center
Department of Neurological Sciences
Paul Greene, MD
Associate Professor of Clinical Neurology
Columbia University
Department of Neurology
Joseph Jankovic, MD
Professor of Neurology
Distinguished Chair in Movement Disorders
Director, Parkinson’s Disease Center and Movement Disorders Clinic
Baylor College of Medicine
Department of Neurology
Barbara I. Karp, MD
Combined NeuroScience Institutional Review Boards
National Institute of Neurological Disorders and Stroke
National Institutes of Health
R. Samuel Mayer, MD
Associate Professor
Vice Chair for Education
Department of Physical Medicine and Rehabilitation
Johns Hopkins University School of Medicine
Deputy Director, Quality Improvement
Department of Physical Medicine and Rehabilitation
The Johns Hopkins Hospital
Fatta B. Nahab, MD
Assistant Professor of Neurology
Director, Functional Imaging of Neurodegenerative Disorders Lab
Miller School of Medicine at the University of Miami
Nutan Sharma, MD, PhD
Assistant in Neurology
Massachusetts General Hospital
Daniel Tarsy, MD
Professor in Neurology
Harvard Medical School
Director, Parkinson’s Disease & Movement Disorders Center
Beth Israel Deaconess Medical Center
Return to Top
LEARNING OBJECTIVES
After attending this activity, participants will demonstrate the ability to:
- EVALUATE patients with dystonia or spasticity to provide proper diagnosis and develop adequate treatment plans.
- DESCRIBE clinically relevant distinctions in dosing and bioavailability between agents available for the management of dystonia or spasticity.
- DISPLAY proficiency in the administration of chemodenervation treatment for dystonia or spasticity.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Return to Top
CME INFORMATION
Accreditation Statement — The Johns Hopkins University School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing medical education for
physicians.
Credit Designation Statement — The Johns Hopkins University School of Medicine designates this
live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure — It is the policy of the Johns Hopkins University
School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to
the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs
or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has
established policies in place that will identify and resolve all conflicts of interest prior to this educational
activity. Detailed disclosures will be made in the course handout materials.
Privacy Statement — The Office of Continuing Medical Education
(CME) at the Johns Hopkins University School of Medicine is committed
to protect the privacy of its members and customers. Johns Hopkins
University SOM CME maintains its Internet site as an information
resource and service for physicians, other health professionals and the
public. Continuing Medical Education at the Johns Hopkins University
School of Medicine will keep your personal and credit information confidential
when you participate in a CME program. Your information
will never be given to anyone outside of the Johns Hopkins University
School of Medicine’s CME program. CME collects only the information
necessary to provide you with the services that you request.
Americans with Disabilities Act (ADA) — The Johns Hopkins University School of Medicine fully
complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if
you have any special needs.
Fee Information — There is no fee for this educational activity
Return to Top
|
